Target intelligence / Profile preview

Myocardin (MYOCD)

Target
MYOCD
Molecular classification
Transcription factor, Transcriptional coactivator
01

Overview

Myocardin is a potent, tissue-restricted transcriptional coactivator encoded by the MYOCD gene, primarily expressed in cardiac and smooth muscle cells[1][4]. It functions by binding to serum response factor (SRF) and activating the expression of genes essential for cardiac and smooth muscle differentiation, including those containing CArG box elements[1][3]. Myocardin is considered a master regulator of smooth muscle cell identity and contractile phenotype, able to induce smooth muscle gene expression even in non-muscle cells and repress the skeletal muscle differentiation program by inhibiting skeletal muscle regulators such as MyoD and myogenin[4][5]. Genetic variants in MYOCD can cause congenital disorders, such as megabladder, and are implicated in cardiovascular developmental abnormalities[2]. Myocardin's precise regulation is essential for vascular homeostasis, and its dysregulation has been implicated in a range of vascular and developmental diseases[3].

Other names
MYCDMGBLmyocardinMYOCD
02

Biological functions

Regulation of gene expressionCardiac muscle cell differentiationSmooth muscle cell differentiationMaintenance of contractile phenotype in smooth muscleRegulation of cell phenotype (promotes smooth muscle, represses skeletal muscle)
03

Disease associations

Cardiovascular diseaseCongenital megabladder (developmental disorder involving smooth muscle)Contribution to vascular disease progressionAlzheimer’s disease (via vascular smooth muscle dysfunction)Other (evidence for involvement in developmental defects affecting bladder and heart)
04

Safety considerations

Potential for lethal congenital disorders when mutatedDisrupted MYOCD function may cause developmental abnormalities in muscle tissues, including heart and urinary bladderAberrant activity can affect vascular tone and phenotype, which could influence disease states such as atherosclerosis, vascular malfunction, or cerebral amyloid clearance

Beyond the preview

Go deeper on Myocardin (MYOCD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myocardin (MYOCD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call